Our projects

Enhancing detection of tuberculosis drug resistanceThe R2D2-xDRTB project is creating a platform to simultaneously evaluate multiple tools for detecting resistance to commonly used TB drugs.

Simplifying malaria treatmentThe WANECAM 3 project is advancing novel non-artemisinin drug combinations as potential innovative single-dose treatments for malaria.

Enhancing clinical research during outbreaksThe ACT-PREP project aims to strengthen capacity for conducting clinical trials in sub-Saharan Africa, with a particular focus on research during...

Improving treatment of cutaneous leishmaniasisThe MAMS4CL project is establishing a clinical trial platform to test improved treatments for cutaneous leishmaniasis, a parasitic disease that...

Advancing modelling capacity to control emerging and re-emerging infectious diseasesThe TIMERA project is strengthening national capacities to use modelling to address the challenges posed...

Factors affecting susceptibility to and severity of mpoxThe DECIPHER-MPOX project is identifying host- and virus-related factors responsible for susceptibility to and the severity of mpox...

Accelerating recovery from choleraThe HUNADIA project is assessing whether a newly developed drug can alleviate the symptoms of cholera, speeding up recovery and shortening or potentially...

Improving tuberculosis detection outside the lungsThe EpiTB project is assessing the clinical impact of a new diagnostic device that is better able to detect TB infections outside the lung.

AI-informed treatment of diarrhoeal diseaseThe CARE-AFRICA project is developing an innovative AI-based tool to guide diagnostics and treatment of diarrhoeal diseases in children under 5 in...

Promoting use of malaria prevention after hospital discharge in childrenThe PDMC Saves Lives project is helping countries identify the best way to introduce a life-saving new approach to...

Disrupting mosquito feeding to prevent malariaThe LASR project is testing whether a newly developed mosquito repellent can reduce the community burden of malaria infections.

Supporting women living with HIV after pregnancyThe DOLPHIN-3 project is assessing whether it is feasible to temporarily transfer women living with HIV from oral antiretroviral therapy (ART)...

Building modelling capacity to enhance disease controlThe IDM-AFRICA project is creating a training programme to strengthen capacity for infectious disease modelling in sub-Saharan Africa. 

Understanding mpox infections during pregnancyThe PREGMPOX project is attempting to find out why mpox virus infections are particularly harmful to pregnant women.

Optimising HIV treatments for pregnant womenGlobal Health EDCTP3 funding will enable the EDCTP2-supported PREGART project to complete a key trial that will provide evidence on the optimal...

Protecting the potency of a key tuberculosis drugThe TASP project is evaluating new approaches to extend the lifespan of the critical tuberculosis drug, bedaquiline, by improving detection...

Progressing a multifunctional antimalarialThe RAMP project is advancing the development of a novel antimalarial drug with the potential to both treat the disease and block the transmission...

Treating epilepsy caused by parasite infection  The NeuroSolve project is evaluating a new treatment for patients who develop epileptic seizures when tapeworm larvae become lodged in their...

Reaching those missing out on vaccinationThe REACH-OUT project is developing strategies to ensure that more ‘zero-dose’ children – those missing out entirely on the benefits of vaccines –...